home / stock / cph:cc / cph:cc news


CPH:CC News and Press, Cipher Pharmaceuticals Inc.

Stock Information

Company Name: Cipher Pharmaceuticals Inc.
Stock Symbol: CPH:CC
Market: TSXC
Website: cipherpharma.com

Menu

CPH:CC CPH:CC Quote CPH:CC Short CPH:CC News CPH:CC Articles CPH:CC Message Board
Get CPH:CC Alerts

News, Short Squeeze, Breakout and More Instantly...

CPH:CC - Cipher Pharmaceuticals Schedules Q4 & Fiscal 2025 Earnings Release and Conference Call

Cipher Pharmaceuticals Schedules Q4 & Fiscal 2025 Earnings Release and Conference Call Cipher Pharmaceuticals Schedules Q4 & Fiscal 2025 Earnings Release and Conference Call Canada NewsWire MISSISSAUGA, ON , March 4, 2026 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (...

CPH:CC - Cipher Pharmaceuticals Announces Health Canada's Acceptance for Review of New Drug Submission for Natroba(TM) (Spinosad)

Cipher Pharmaceuticals Announces Health Canada's Acceptance for Review of New Drug Submission for Natroba™ (Spinosad) Canada NewsWire MISSISSAUGA, ON , Jan. 28, 2026 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) (" Cipher " or the " Company ") today ann...

CPH:CC - Cipher Pharmaceuticals Reports Third Quarter 2025 Results

Cipher Pharmaceuticals Reports Third Quarter 2025 Results Canada NewsWire (All figures are presented in U.S. Dollars) Adjusted EBITDA 1 in Q3 2025 was $7.3 million , an increase of 79% over Q3 2024 Natroba TM sales were $8.1 million during the quarter, a sequential inc...

CPH:CC - Expected Canadian Company Earnings on Thursday, November 6th, 2025

Lundin Gold Inc. (LUG:CA) is expected to report $1.05 for Q3 2025 ARC Resources Ltd. (ARX:CA) is expected to report $0.57 for Q3 2025 WELL Health Technologies Corp. (WELL:CA) is expected to report $0.03 for Q3 2025 Lassonde Industries Inc. Class A Subordinate Voting Shares (LAS.A:CA) ...

CPH:CC - 4 Best-performing Canadian Pharma Stocks of 2025

2025-11-04 04:15:00 ET From established players to up-and-coming firms, Canada's pharmaceutical landscape is diverse and dynamic. Canadian drug companies are working to discover and develop major innovations amidst an increasingly competitive global landscape. Rising technologies su...

CPH:CC - Cipher Pharmaceuticals Schedules Q3 2025 Earnings Release and Conference Call

Cipher Pharmaceuticals Schedules Q3 2025 Earnings Release and Conference Call Canada NewsWire MISSISSAUGA, ON , Oct. 29, 2025 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) (" Cipher " or the " Company ") today announced that it will release its financial resul...

CPH:CC - Cipher Pharmaceuticals Receives Successful Arbitration Award

Cipher Pharmaceuticals Receives Successful Arbitration Award Canada NewsWire MISSISSAUGA, ON , Oct. 14, 2025 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) (" Cipher " or the " Company ") has received a favourable award from an extensive and comprehensive ...

CPH:CC - Cipher Pharmaceuticals Announces the Passing of Director Mr. Harold Wolkin

Cipher Pharmaceuticals Announces the Passing of Director Mr. Harold Wolkin Canada NewsWire MISSISSAUGA, ON , Aug. 26, 2025 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) (" Cipher " or the " Company ") announces with great sadness the passi...

CPH:CC - Cipher Pharmaceuticals Reports Second Quarter 2025 Results, Including Record Revenue

Cipher Pharmaceuticals Reports Second Quarter 2025 Results, Including Record Revenue Canada NewsWire (All figures are presented in U.S. Dollars) Highest single-quarter revenue in the Company's history with total revenue of $13.4 million in Q2 2025 Adjusted EB...

CPH:CC - Expected Canadian Company Earnings on Thursday, August 7th, 2025

Calfrac Well Services Ltd. (CFW:CA) is expected to report $0.14 for Q2 2025 Jamieson Wellness Inc. (JWEL:CA) is expected to report $0.43 for Q2 2025 Strathcona Resources Ltd. (SCR:CA) is expected to report $0.67 for Q2 2025 Stella-Jones Inc. (SJ:CA) is expected to report $1.84 for Q2 ...

Next 10